Literature DB >> 46051

Urinary-tract infection: localisation and virulence of Escherichia coli.

G M Kalmanson, H J Harwick, M Turck, L B Guze.   

Abstract

Virulence of 15 strains of Escherichia coli from the human upper urinary tract was compared with that of 16 strains from the lower urinary tract, using an ascending infection in the mouse. No significant difference was found. There was no significant difference in frequency of K antigen and ability to ferment dulcitol between 32 lower strains and 31 upper strains. However, 22 strains containing K antigen, regardless of anatomical site of localisation, were more significantly likely to cause infection than 9 strains with no antigen. Similarly, 23 dulcitolfermenting strains, regardless of site of localisation, were significantly more likely to cause infection than 8 non-fermenting strains.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 46051     DOI: 10.1016/s0140-6736(75)91430-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  10 in total

1.  The O4 specific antigen moiety of lipopolysaccharide but not the K54 group 2 capsule is important for urovirulence of an extraintestinal isolate of Escherichia coli.

Authors:  T Russo; J J Brown; S T Jodush; J R Johnson
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

Review 2.  Virulence factors in Escherichia coli urinary tract infection.

Authors:  J R Johnson
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

3.  Vaginal Inoculation of Uropathogenic Escherichia coli during Estrus Leads to Genital and Renal Colonization.

Authors:  Christen K Robinson; Panatda Saenkham-Huntsinger; Braden S Hanson; L Garry Adams; Sargurunathan Subashchandrabose
Journal:  Infect Immun       Date:  2022-03-31       Impact factor: 3.609

4.  Virulence of urinary and faecal Escherichia coli in relation to serotype, haemolysis and haemagglutination.

Authors:  J F van den Bosch; P Postma; P A Koopman; J de Graaff; D M MacLaren; D G van Brenk; P A Guinée
Journal:  J Hyg (Lond)       Date:  1982-06

5.  Correlation between uropathogenic properties of Escherichia coli from urinary tract infections and the antibody-coated bacteria test and comparison with faecal strains.

Authors:  H J Brooks; B A Benseman; J Peck; K A Bettelheim
Journal:  J Hyg (Lond)       Date:  1981-08

6.  Investigation of the effect of K antigen in Escherichia coli urinary tract infections by use of a mouse model.

Authors:  A M Nicholson; A A Glynn
Journal:  Br J Exp Pathol       Date:  1975-12

7.  Screening for cross-reacting capsular polysaccharide K antigens of Escherichia coli using antiserum agar.

Authors:  G W Counts; M Turck
Journal:  J Clin Microbiol       Date:  1977-04       Impact factor: 5.948

8.  Virulence of Escherichia coli in acute pyelonephritis, acute cystitis and asymptomatic bacteriuria.

Authors:  J F van den Bosch; P L Oe; P Postma; J de Graaff; D M MacLaren; W H Jansen; P A Guinée
Journal:  Antonie Van Leeuwenhoek       Date:  1980       Impact factor: 2.271

9.  Virulence of Escherichia coli in experimental hematogenous pyelonephritis in mice.

Authors:  J F van den Bosch; J de Graaff; D M MacLaren
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

10.  Virulence of Escherichia coli strains isolated from urine of patients with acute cystitis and from faeces of healthy women.

Authors:  J F van den Bosch; P Postma; D van Brenk; P A Guinée; J de Graaff; D M MacLaren
Journal:  Antonie Van Leeuwenhoek       Date:  1981       Impact factor: 2.271

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.